MicroRNA profiling in human diploid fibroblasts uncovers miR-519






































MicroRNAs are short (~ 22-nt) RNA molecules that 
modulate changes in gene expression [1,2].  They are 
generated from precursor transcripts (primary 
microRNAs) which are exported to the cytoplasm and 
are cleaved by Dicer; mature miRNAs then assemble 
into ribonucleoprotein silencing complexes (RISC) that 
are recruited to specific mRNAs [3].  MicroRNAs 
function primarily as repressors of mRNA stability and 
translation [4].  Through their influence on the patterns 
of expressed genes, microRNAs have been implicated 
in numerous physiologic processes, such as develop-
ment of the muscular, immune, neuronal, epithelial and 
other systems, and in pathologies including neuro-
degeneration and cancer [5-8].  The latter studies have 








































mor suppressors (TS-miRNAs) or tumor promoters 
(oncomiRs) [9]. 
 
Cellular senescence is achieved when cells reach the 
end of their replicative lifespan [10,11].  It is believed to 
represent a tumor-suppressive mechanism and a 
contributing factor in aging [12,13].  MicroRNAs have 
been implicated in replicative senescence, since loss of 
miRNA biogenesis through Dicer ablation causes 
senescence in primary cells [14].  Several specific 
miRNAs were reported to be differentially expressed in 
senescent cells compared to young, proliferating cells.  
For example, miRNA-146a and miR-146b are up-
regulated in senescent cells and modulate inflammatory 
responses by suppressing secretion of IL-6 and IL-8 and 
by downregulating IRAK1 [15].   
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and miR-141) that jointly lower expression of the kinase 
MKK4 were found to decline during replicative 
senescence and to contribute to the senescence process 
[16].  miR-24 was also found to regulate translation of 
the cyclin-dependent kinase inhibitor p16, thereby 
allowing increased p16 expression in senescent cells [17].   
 
Several miRNAs differentially expressed with aging have 
also been identified.  For example, miR-17, miR-19b, 
miR-20a, and miR-106a were less abundant in cells from 
older humans [18]. Reduced expression of miR-103, 
miR-107, miR-128, miR-130a, miR-155, miR-24, miR-
221, miR-496, and miR-1538 in older individuals was 
also recently reported [19].  Age-regulated changes in the 
expression of microRNAs were also found in mouse liver 
and brain [20,21].  MicroRNA changes in Ames dwarf 
mouse liver led to the identification of microRNAs that 
might delay aging [22].  Studies in Caenorhabditis 
elegans revealed that the microRNA lin-4 represses lin-
14 transcripts and lin-14 protein to extend  lifespan by 
reducing DAF-16; miRNA profiling in C elegans 
provided evidence that microRNAs may potently 
influence the biology of aging [23-25]. 
 
Many studies have focused on the role of microRNAs in 
tumorigenesis and age-related diseases.  Here, we have 



























cative senescence of WI-38 human diploid fibroblasts 
(HDFs).  We identified subsets of microRNAs that were 
differentially expressed in young compared with 
senescent WI-38 cells.  miR-519, a microRNA that 
suppresses tumorigenesis and lowers expression of 
RNA-binding protein HuR, was upregulated in 
senescent cells.  Overexpression of miR-519 induced 
senescence in WI-38 and HeLa cells.  Our data support 
the hypothesis that senescence-associated changes in 
microRNA expression patterns can affect the 




Global changes in microRNAs between early-
passage and senescent WI-38 human diploid 
fibroblasts  
 
Compared with early-passage, ‘young’ proliferating [Y, 
at population doubling (pdl) 22] WI-38 cells, the 
senescent (S, pdl 52) WI-38 cells displayed a flattened 
morphology and senescence-associated (SA) β-
galactosidase (SA-β-gal) activity, a widely used 
senescence marker [26,27] (Figure 1A).  Western blot 
analysis also revealed that senescent cells expressed 
lower levels of SIRT1 and HuR, whereas p16 and p53 


























Figure  1.  Characterization  of  early‐passage  and  senescent  WI‐38
cells.  (A) Micrographs illustrating β‐galactosidase activity in young (Y) early‐
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affected by replicative senescence, we studied 
transcriptome-wide changes in microRNAs using 
miRNome arrays (not shown); we then validated 
individual microRNAs by reverse transcription (RT) 
followed by real-time, quantitative (q)PCR amplification 
(see Materials and Methods).  Depicted in Figures 2 and 















































validated using sequence-specific qPCR primers.  As 
shown in Figure 2, several microRNAs were markedly 
more abundant in senescent cells (e.g., miR-1204, miR-
663, miR-548b-3p and miR-431).  Other microRNAs 
were expressed at lower levels in senescent cells [e.g., 
miR-24, miR-141, and miR-10a (Figure 3, Supplemental 
Table S1)].  MicroRNAs changing less than twofold with 




































































































































































Figure  3.  MicroRNAs  downregulated  in  senescent  cells.  RNA  was  extracted  and  analyzed  as
explained in the legend of Figure 2.  Data show the means and S.D. from three independent experiments.   
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We were particularly interested in the miR-519 family.  
miR-519 was recently found to inhibit translation of the 
RNA-binding protein HuR through its interaction with 
the HuR coding region [31].  In a separate study, miR-
519 suppressed the growth of tumor xenografts in an 
HuR-dependent manner [32].  Given that HuR promotes 
cell proliferation and decreases senescence [33,34], we 
hypothesized that the elevated miR-519 in senescent cells 
(Figure 4A) might lower HuR expression in WI-38 
HDFs, and hence promote senescence.  To test this 
possibility, we overexpressed miR-519a in young-HDFs 
(Figure 4B);  western blot analysis confirmed that miR-









































keeping with earlier results [31], miR-519a did not 
influence the levels of HuR mRNA (Figure 4D), in 
agreement with the view that miR-519a inhibited HuR 
mRNA translation without affecting HuR mRNA 
stability.  Moreover, sustained miR-519a overexpression 
for 4 weeks caused a marked reduction in cell number as 
compared to control transfection groups (Figure 4E).   
miR-519a-overexpressing cells also showed increased 
SA-β-gal activity (Figure 4F) and elevated expression of 
the senescence marker p27 [35,36] (Figure 4G, bottom).  
Together, these data indicate that miR-519a induced 
cellular senescence and inhibited cell proliferation, 
resulting in accelerated senescence.  They further suggest 
that miR-519a-induced senescence may be mediated in 
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As indicated above, miR-519 was found to suppress 
tumor growth [32].  Since cellular senescence is 
considered to be an anti-tumorigenic process, we 
examined the effect of miR-519 on the senescent 
phenotype of cancer cells.  Upon miR-519a 
overexpression (Figure 5A), HeLa cell numbers 
declined  significantly (Figure 5B).  Five days after 
transfection of miR-519a, cells showed a strong 
increase in SA-β-gal activity compared to the control 
transfection group (Figure 5C);  in addition, miR-519-
induced senescence in HeLa cells was accompanied by 
increased levels of the senescence markers p53 and p27 
(Figure 5D).  Together, these data indicate that miR-519 
reduced HeLa cell proliferation and promoted HeLa cell 
senescence.  Accordingly, we postulate that one of the 
mechanisms by which miR-519 suppress tumor growth 
is by inducing senescence, and further propose that 
miR-519 triggers senescence –at least in part– by 




Cells become senescent as a result of factors such as the 
accumulation of reactive oxygen species, DNA damage, 
erosion of telomeres, and oncogenic activation.   
Collectively, these triggers cause cells to undergo 
morphological changes, to become unable to replicate 
DNA and to display altered gene expression patterns 
[10-13].  Here, we investigated microRNA levels in WI-
38 human diploid fibroblasts by comparing microRNA 
patterns in senescent relative to young, proliferating 
cells.  Among the microRNAs showing increasing 
abundance with senescence, miR-519 was of particular 
interest because it was shown to inhibit translation of 
HuR and to diminish tumor growth [31,32].  Through 
its influence on the expression of many genes, HuR 
plays a key role in cell proliferation, tumorigenesis, and 
senescence [37,38].  We found that overexpression of 
miR-519a decreased HuR levels, lowered cell 
proliferation, and promoted replicative senescence in 
both WI-38 and HeLa cells. 
 
microRNAs and senescence  
 
We previously used miRNA microarrays to identify 
changes in a limited number of microRNAs in senescent 
cells [16].  Here, we have expanded this analysis and 
have verified many individual microRNAs whose 
abundance changes with replicative senescence.  Many 
of them target key proteins implicated in senescence 
and cancer.  For example, miR-146b is upregulated in 
senescent cells (Figure 2), in keeping with earlier 
findings that miR-146a and miR-146b increased with 
senescence and repressed the senescence-associated 
inflammatory mediators IL-6 and IL-8 [15].  miR-34a 
regulates SIRT1 expression and induced senescence of 
cancer cells [39-41]; here, we observed higher miR-34c 
(not miR-34a) in senescent cells, likely a reflection of 
the variability and complexity of the senescence 
process.  Several let-7 members were also upregulated 
in senescent cells (Figure 2 and Supplemental Figure 
S1);  this observation supports the view that the ability 
of let-7 microRNAs can suppress tumor growth 
[reviewed in 42], which could contribute to the 
senescence process.  Similarly, upregulation of miR-20 
in senescence cells correlates with the ability of miR-20 
to inhibit proliferation of K562 human 
erythromyeloblastoid leukemia cells [43].  In 
conjunction with the finding that miR-519 reduced 
tumorigenesis in a xenograft model [32], we propose 
that the coordinated action of senescence-upregulated 
microRNAs can suppress tumor growth by reducing the 
levels of oncogenes or tumor promoters.  
 
Conversely, many microRNAs were downregulated in 
senescent cells (Figure 3).  Among the myriad of 
senescence-associated proteins that they might regulate, 
these microRNAs likely repress several tumor 
suppressors.  In this regard, as miR-21 has been shown 
to lower expression of the tumor suppressor PTEN [44], 
the downregulated of miR-21 in senescent cells (Figure 
3) could allow increased PTEN expression, in turn 
reducing tumor cell proliferation, migration, and 
invasion [45].  
 
miR-519a-induced senescence by lowering HuR 
 
We previously reported that miR-519 represses the 
production of HuR, an RNA-binding protein which is 
highly abundant in cancer cells and is low in 
untransformed cells [11,38].  HuR overexpression 
delays the senescent phenotype while the loss of HuR 
enhances it [11].  Moreover, while HuR levels are high 
in tumors and low in normal tissues, miR-519 levels are 
high in normal tissues and low in cancer tissues [32].  
Since HuR potently enhances the expression of cancer-
promoting proteins, and reducing HuR levels promotes 
HDF senescence [11,38], we propose that miR-519 
represses tumor growth at least in part, by lowering 
HuR and thereby promoting senescence (Figs. 4 and 5).  
Additionally, miR-519 could further repress tumor 
growth by lowering the expression of other genes, such 
as ABCG2 or HIF-1α [46,47]. 
 
In summary, we have identified collections of 
microRNAs displaying altered abundance with 
replicative senescence.  As shown here for miR-519, we 
postulate that these changes help to meet the needs of 
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growth arrest.  Future studies will help to recognize 
more fully the proteins and processes modulated by 
senescence-regulated microRNAs. 
 
MATERIAL AND METHODS 
 
Cell culture, transfections, and β-galactosidase staining. 
Early-passage, proliferating (‘young’, ~20 to 30 pdl) 
and late-passage, senescent (~50 to 55 pdl) WI-38 
human diploid fibroblasts (HDFs; Coriell Cell 
Repositories) were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM, Invitrogen) supplemented 
with 10% fetal bovine serum and 0.1 mM nonessential 
amino acids (Invitrogen).  HeLa cells were cultured in 
DMEM supplemented with 10% FBS and antibiotics.   
miR-519a (Ambion) or control siRNA 
(AATTCTCCGAACGTGTCACGT, Qiagen) were 
transfected at a final concentration of 100 nM using 
Lipofectamine 2000 (Invitrogen).  Where indicated, 
transfections were performed every 7 days for 4 weeks.  
WI-38 HDFs and HeLa cells were stained with a 
senescence-associated  β-galactosidase (Cell Signaling 
Technology) detection kit, according to the 
manufacturer’s protocol.  
 
RNA isolation and miRNA profiling. Total cellular RNA 
was isolated using Trizol (Invitrogen).  Isolated RNA 
was used to measure miRNA levels in young and 
senescent cells with a 7900HT real-time PCR instrument 
(Applied Biosystems).  All microRNAs were measured 
and validated using miRNA-specific forward primers 
(Supplemental Table S2) and a universal reverse primer 
(System Biosciences, SBI), according to the 
manufacturer’s protocol.  The levels of U1 snRNA, used 
for normalization, were determined using the specific 
forward primer CGACTGCATAATTTGTGGTAGTGG.  
 
Protein analysis. Whole-cell lysates were prepared with 
RIPA buffer [10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 
1% NP-40, 1 mM EDTA, 0.1% SDS, and 1 mM 
dithiothreitol].  Proteins were resolved by SDS–
polyacrylamide gel electrophoresis and transferred to 
polyvinylidene difluoride membranes (Invitrogen).   
After incubation with primary antibodies recognizing 
SIRT1, HuR, p16, p53, p27, GAPDH (all from Santa 
Cruz Biotechnology) or β-actin (Abcam), blots were 
incubated with the appropriate secondary antibodies and 
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